- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05725486
N-3 Polyunsaturated Fatty Acids Enriched Chicken Meet and Cardiovascular Function
Effects of N-3 Polyunsaturated Fatty Acids Enriched Chicken Meet on Cardiovascular Function
Evidence from multiple experimental, epidemiological, and clinical studies indicate that n-3 polyunsaturated fatty acids (n-3 PUFAs) may exert their cardiovascular (CV) protective effect, at least in part, by improving vascular endothelium-dependent function. Previously, the investigators demonstrated the significant beneficiary effect of consumption of n-3 PUFA-enriched hen eggs on microvascular endothelium-dependent reactivity, even in young healthy individuals.
The hypothesis of this research is that the consumption of n-3 PUFAs in the form of functionally enriched chicken meet has a beneficial effect on vascular reactivity measured in different vascular beds, and the lipid profile with a positive effect on the reduction of oxidative stress and inflammatory response in healthy sedentary individuals.
The main goal of this study is to investigate the influence of n-3 PUFAs functionally enriched chicken meet on vascular and endothelial function in a population of healthy young subjects and active athletes.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ines Drenjancevic
- Phone Number: +385-31-51-28-00
- Email: ines.drenjancevic@mefos.hr
Study Locations
-
-
-
Osijek, Croatia, 31000
- Recruiting
- Scientific Center of Excellence for Personalized Health Care, Josip Juraj Strossayer University of Osijek
-
Contact:
- Ivana Jukić, MD, PhD
- Email: ivana.jukic@mefos.hr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- young healthy sedentary individuals - did not perform regular physical activities for at least 12 months before conducting the study
- young healthy active athletes - have a minimum of 5 training sessions per week (mainly endurance training) for at least 12 months prior to conducting the study
Exclusion Criteria:
- smoking
- hypertension
- coronary disease
- diabetes
- hyperlipidemia
- kidney damage
- cerebrovascular and peripheral artery diseases
- and any other disease that could have an impact on vascular and endothelial function
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: n-3 PUFA
Intake of n-3 PUFAs enriched chicken meet for three weeks
|
Intake of n-3 PUFAs enriched chicken meet for three weeks.
|
EXPERIMENTAL: Control
Intake of regular chicken meet for three weeks
|
Intake of regular chicken meet for three weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Microvascular endothelial function
Time Frame: 3 weeks
|
Cutaneous microvascular blood flow will be measured by Laser Doppler Flowmetry in response to vascular occlusion (post occlusive reactive hyperaemia - PORH), in response to iontophoresis of acetylcholine (ACh) and local thermal hyperemia (LTH).
|
3 weeks
|
Macrovascular endothelial function
Time Frame: 3 weeks
|
Measurement of flow mediated dilation (FMD) of brachial artery using ultrasound.
|
3 weeks
|
Cerebrovascular reactivity
Time Frame: 3 weeks
|
Measurement of cerebrovascular blood flow using transcranial color Doppler (TCD).
|
3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lipid profile
Time Frame: 3 weeks
|
Measurement of plasma cholesterol, HDL cholesterol, LDL cholesterol and triglycerides level.
|
3 weeks
|
Oxidative stress status
Time Frame: 3 weeks
|
Measurement of Thiobarbituric Acid Reactive Substances (TBARS).
|
3 weeks
|
Systemic hemodynamics
Time Frame: 3 weeks
|
Non-invasive assessment of systemic hemodynamics using impedance cardiography (CardioScreen 2000) - SV Stroke Volume (mL), CO Cardiac Output (L/min) and SVRI Systemic Vascular Resistance Index (dyn.s.cm-5 m2).
|
3 weeks
|
Serum Pro- and Anti-Inflammatory Cytokines, Chemokines, Growth Factors and Soluble Cell Adhesion Molecules Protein Concentration
Time Frame: 3 weeks
|
Measurement of serum protein concentration (pg/mL) of various pro- and anti-inflammatory cytokines, chemokines, growth factors and soluble cell adhesion molecules by kits and panels for multiplex protein quantitation using the Luminex 200 instrument platform.
|
3 weeks
|
Body composition
Time Frame: 3 weeks
|
Body composition and body fluid status measurement by a four-terminal portable impedance analyzer.
Based on the value of skin resistance (Ohm) empirically derived formulas (the original manufacturer's software) will be used to calculate the estimated Fat Free Mass (FFM kg) and Fat (Fat Mass kg).
|
3 weeks
|
Body fluid status
Time Frame: 3 weeks
|
Body fluid status measurement by a four-terminal portable impedance analyzer.
Based on the value of skin resistance (Ohm) empirically derived formulas (the original manufacturer's software) will be used to calculate the estimated Total Body Water (TBW L), Extracellular Water (ECW L), Intracellular Water (ICW L), Plasma Fluid (PF L) and Interstitial Fluid (IF L).
|
3 weeks
|
Oxidative stress status
Time Frame: 3 weeks
|
Measurement of Ferric-Reducing Ability of Plasma (FRAP).
|
3 weeks
|
Oxidative stress status
Time Frame: 3 weeks
|
Measurement of enzyme activity assay of glutathione peroxidase (GPx).
|
3 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2158614622108
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on n-3 Polyunsaturated Fatty Acids
-
Josip Juraj Strossmayer University of OsijekUnknownVitamin E | Selenium | Lutein | n-3 Polyunsaturated Fatty AcidsCroatia
-
Josip Juraj Strossmayer University of OsijekUnknownOmega-3 Polyunsaturated Fatty AcidsCroatia
-
Zhejiang UniversityNational Institute of Health and NutritionCompletedMortality | Polyunsaturated Fatty Acids
-
Kuang Tien General HospitalCompletedMigraine | Omega-3 Polyunsaturated Fatty AcidsTaiwan
-
USDA Grand Forks Human Nutrition Research CenterUnited States Department of Agriculture (USDA); University of North DakotaCompletedOmega-3 Fatty Acids | Lipid PeroxidationUnited States
-
Medical University of South CarolinaAker Biomarine Antarctic ASCompletedFatty Acids, Omega-3 | Cognition | Nutrition | Resilience, Psychological | Psychology, MilitaryUnited States
-
B. Braun Melsungen AGCompletedPreterm Infants | Parenteral Nutrition n-3 Fatty AcidsGermany
-
University of HohenheimCompletedMicronutrients | Human Nutrition, Omega-3 Fatty Acids, MicroalgaeGermany
-
University of Eastern FinlandCompletedGenetics | Fatty AcidsFinland
-
University of UlsterLund University; University of Rochester; Ministry of Health, Republic of SeychellesCompletedPolyunsaturated Fatty Acid (PUFA) StatusUnited Kingdom
Clinical Trials on N-3 PUFAs Chicken Meet
-
Laval UniversityCompleted
-
Northumbria UniversityGinsana SACompletedCognitive Function | MoodUnited Kingdom
-
Sun Yat-sen UniversityUnknownGestational Diabetes MellitusChina
-
Instituto Nacional de Ciencias Medicas y Nutricion...CompletedIntestinal FailureMexico
-
Università degli Studi di BresciaCompletedHeart Failure | Dilated CardiomyopathyItaly
-
Ohio State University Comprehensive Cancer CenterCompletedDuctal Breast Carcinoma in Situ | Breast Cancer, Stage I | Breast Cancer, Stage II | Breast Cancer, Stage IIIUnited States
-
Josip Juraj Strossmayer University of OsijekUnknownOmega-3 Polyunsaturated Fatty AcidsCroatia
-
University of DundeeWithdrawnArrhythmia | Defibrillators, ImplantableUnited Kingdom
-
Coordinación de Investigación en Salud, MexicoInstituto Mexicano del Seguro Social; National Council of Science and Technology...CompletedMalnutrition | Acute Lymphoblastic LeukemiaMexico
-
Coordinación de Investigación en Salud, MexicoCompletedSevere Sepsis | Organ Dysfunction SyndromeMexico